Brokerages expect Agilent Technologies Inc (NYSE:A) to report earnings of $0.63 per share for the current fiscal quarter, according to Zacks. Six analysts have provided estimates for Agilent Technologies’ earnings, with the lowest EPS estimate coming in at $0.62 and the highest estimate coming in at $0.67. Agilent Technologies reported earnings per share of $0.59 during the same quarter last year, which indicates a positive year-over-year growth rate of 6.8%. The company is scheduled to announce its next earnings report on Tuesday, August 21st.
On average, analysts expect that Agilent Technologies will report full year earnings of $2.67 per share for the current year, with EPS estimates ranging from $2.65 to $2.75. For the next fiscal year, analysts anticipate that the firm will post earnings of $2.94 per share, with EPS estimates ranging from $2.83 to $3.07. Zacks’ EPS averages are an average based on a survey of analysts that cover Agilent Technologies.
Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Monday, May 14th. The medical research company reported $0.65 EPS for the quarter, beating the Zacks’ consensus estimate of $0.64 by $0.01. Agilent Technologies had a net margin of 5.02% and a return on equity of 18.01%. The firm had revenue of $1.21 billion for the quarter, compared to analysts’ expectations of $1.21 billion. During the same quarter in the prior year, the company posted $0.58 earnings per share. The business’s revenue for the quarter was up 9.4% on a year-over-year basis.
A has been the topic of a number of research analyst reports. Zacks Investment Research downgraded shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Wednesday, May 16th. Morgan Stanley decreased their price target on shares of Agilent Technologies from $95.00 to $91.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 11th. Cowen upgraded shares of Agilent Technologies from a “market perform” rating to an “outperform” rating in a research report on Tuesday, May 15th. ValuEngine downgraded shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Tuesday, May 29th. Finally, Goldman Sachs Group upgraded shares of Agilent Technologies from a “neutral” rating to a “buy” rating in a research report on Monday, April 9th. Three equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $72.75.
Shares of Agilent Technologies stock opened at $61.84 on Monday. The company has a market cap of $19.61 billion, a P/E ratio of 26.20, a P/E/G ratio of 2.14 and a beta of 1.28. Agilent Technologies has a twelve month low of $58.22 and a twelve month high of $75.00. The company has a debt-to-equity ratio of 0.39, a quick ratio of 2.88 and a current ratio of 3.32.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 25th. Stockholders of record on Tuesday, July 3rd will be given a dividend of $0.149 per share. The ex-dividend date of this dividend is Monday, July 2nd. This represents a $0.60 annualized dividend and a dividend yield of 0.96%. Agilent Technologies’s payout ratio is 25.42%.
In other news, Director Boon Hwee Koh sold 6,931 shares of the firm’s stock in a transaction on Tuesday, June 12th. The shares were sold at an average price of $66.38, for a total transaction of $460,079.78. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.
A number of institutional investors and hedge funds have recently bought and sold shares of A. Compagnie Lombard Odier SCmA purchased a new position in Agilent Technologies during the fourth quarter valued at $126,000. Point72 Asia Hong Kong Ltd grew its stake in Agilent Technologies by 303.2% during the first quarter. Point72 Asia Hong Kong Ltd now owns 2,859 shares of the medical research company’s stock valued at $191,000 after acquiring an additional 2,150 shares in the last quarter. Signaturefd LLC purchased a new position in Agilent Technologies during the first quarter valued at $201,000. Premia Global Advisors LLC purchased a new position in Agilent Technologies during the fourth quarter valued at $204,000. Finally, BancorpSouth Bank purchased a new position in Agilent Technologies during the fourth quarter valued at $235,000.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.
Get a free copy of the Zacks research report on Agilent Technologies (A)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.